The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model

被引:8
作者
Bae, In-Ho [1 ,2 ]
Jeong, Myung Ho [1 ,2 ,3 ]
Kim, Ju Han [2 ,3 ]
Park, Yong Hwan [2 ,4 ]
Lim, Kyung Seob [1 ,2 ]
Park, Dae Sung [1 ,2 ]
Shim, Jae Won [1 ,2 ]
Kim, Jung Ha [1 ,2 ]
Ahn, Youngkeun [2 ,3 ]
Hong, Young Joon [2 ,3 ]
Sim, Doo Sun [2 ,3 ]
机构
[1] Chonnam Natl Univ Hosp, Korea Minist Hlth & Welf, Cardiovasc Convergence Res Ctr, Gwangju, South Korea
[2] Korea Cardiovasc Stent Res Inst, Jangsung, South Korea
[3] Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Cardiol,Dept Internal Med, Chang Won, South Korea
关键词
Stents; Hyaluronic acid; Paclitaxel; Preclinical drug evaluation; Coronary restenosis; BARE METAL STENTS; ELUTING-STENTS; LATE THROMBOSIS; IN-VIVO; EFFICACY; ACTIVATION; DELIVERY; SAFETY; METAANALYSIS; ANGIOPLASTY;
D O I
10.4070/kcj.2016.0203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Hyaluronic acid (HA) is highly biocompatible with cells and the extracellular matrix. In contrast to degradation products of a synthetic polymer, degradation products of HA do not acidify the local environment. The aim of this study was to fabricate an HA-coated paclitaxel (PTX)-eluting stent via simple ionic interactions and to evaluate its effects in vitro and in vivo. Materials and Methods: HA and catechol were conjugated by means of an activation agent, and then the stent was immersed in this solution (resulting in a HA-coated stent). After that, PTX was immobilized on the HA-coated stent (resulting in a hyaluronic acid-coated paclitaxel-eluting stent [H-PTX stent]). Study groups were divided into 4 groups: bare metal stent (BMS), HA, H-PTX, and poly (L-lactide)coated paclitaxel-eluting stent (P-PTX). Stents were randomly implanted in a porcine coronary artery. After 4 weeks, vessels surrounding the stents were isolated and subjected to various analyses. Results: Smoothness of the surface was maintained after expansion of the stent. In contrast to a previous study on a PTX-eluting stent, in this study, the PTX was effectively released up to 14 days (a half amount of PTX in 4 days). The proliferation of smooth muscle cells was successfully inhibited (by 80.5+12.110/o at 7 days of culture as compared to the control) by PTX released from the stent. Animal experiments showed that the H-PTX stent does not induce an obvious inflammatory response. Nevertheless, restenosis was clearly decreased in the H-PTX stent group (9.8+3.25%) compared to the bare-metal stent group (29.7+8.11%). Conclusion: A stent was stably coated with P-D( via simple ionic interactions with HA. Restenosis was decreased in the H-PTX group. These results suggest that HA, a natural polymer, is suitable for fabrication of drug-eluting stents (without inflammation) as an alternative to a synthetic polymer.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 32 条
[1]   Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in Swine [J].
Albrecht, Thomas ;
Speck, Ulrich ;
Baier, Claudia ;
Wolf, Karl-Juergen ;
Boehm, Michael ;
Scheller, Bruno .
INVESTIGATIVE RADIOLOGY, 2007, 42 (08) :579-585
[2]   Mechanical behavior and in vivo properties of newly designed bare metal stent for enhanced flexibility [J].
Bae, In-Ho ;
Lim, Kyung-Seob ;
Park, Jun-Kyu ;
Park, Dae-Sung ;
Lee, So-Youn ;
Jang, Eun-Jae ;
Ji, Mi Seon ;
Sim, Doo Sun ;
Hong, Young Joon ;
Ahn, Youngkeun ;
Park, Jong Chun ;
Cho, Jeong Gwan ;
Kang, Jung Chaee ;
Kim, In-Su ;
Nah, Jae-Woon ;
Jeong, Myung-Ho .
JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, 2015, 21 :1295-1300
[3]   Gene therapy for restenosis - Getting nearer the heart of the matter [J].
Baek, S ;
March, KL .
CIRCULATION RESEARCH, 1998, 82 (03) :295-305
[4]   Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis [J].
Bangalore, Sripal ;
Toklu, Bora ;
Amoroso, Nicholas ;
Fusaro, Mario ;
Kumar, Sunil ;
Hannan, Edward L. ;
Faxon, David P. ;
Feit, Frederick .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
[5]   Influence of sulfation on platelet aggregation and activation with differentially sulfated hyaluronic acids [J].
Barbucci, R ;
Lamponi, S ;
Magnani, A ;
Poletti, LF ;
Rhodes, NP ;
Sobel, M ;
Williams, DF .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1998, 6 (02) :109-115
[6]  
Buszman P, 2007, KARDIOL POL, V65, P1041
[7]   Polyglycolic acid-induced inflammation: Role of hydrolysis and resulting complement activation [J].
Ceonzo, K ;
Gaynor, A ;
Shaffer, L ;
Kojima, K ;
Vacanti, CA ;
Stahl, GL .
TISSUE ENGINEERING, 2006, 12 (02) :301-308
[8]   Novel Fabrication of MicroRNA Nanoparticle-Coated Coronary Stent for Prevention of Post-Angioplasty Restenosis [J].
Che, Hui-Lian ;
Bae, In-Ho ;
Lim, Kyung Seob ;
Uthaman, Saji ;
Song, In Taek ;
Lee, Haeshin ;
Lee, Duhwan ;
Kim, Won Jong ;
Ahn, Youngkeun ;
Park, In-Kyu ;
Jeong, Myung-Ho .
KOREAN CIRCULATION JOURNAL, 2016, 46 (01) :23-32
[9]  
CLOWES AW, 1985, LAB INVEST, V52, P611
[10]  
Commandeur Suzan, 2006, J Interv Cardiol, V19, P500, DOI 10.1111/j.1540-8183.2006.00198.x